Info@ThinkPinkRocks.com

Bevacizumab QoL impact highlighted in ovarian cancer patients

The ICON7 study results suggest that improved progression-free survival with bevacizumab therapy for high-risk ovarian cancer may come at the cost of health-related quality of life.

Follow this link:
Bevacizumab QoL impact highlighted in ovarian cancer patients

Share

Leave a Reply

Solve : *
21 + 9 =